Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study

Michael J. Koren, Robert C. Scott, Jae B. Kim, Beat Knüsel, Thomas Liu, Lei Lei, Michael A. Bolognese, Scott M. Wasserman

The Lancet · 2012 · 362 citations · 21 references

Concepts

References

21